Anterix Q4 Call Highlights Spectrum Demand but Cash Flow Concerns Persist

What happened

Anterix reported Q4 earnings emphasizing rising spectrum demand and a shift from utility talks to actual deployments, citing spectrum scarcity and recent contract wins as catalysts for stronger pricing. However, financials still show minimal recurring spectrum revenue ($1.6M) and reliance on non-cash gains, underscoring the gap between narrative and operating reality. The $114M contracted backlog provides near-term cash visibility, but liquidity remains thin with ~$39M cash against ~$43M in known commitments, leaving little room for delays. While the strategic review and new offerings like TowerX/CatalyX could accelerate adoption, there are no disclosed customers or revenue from these initiatives yet. The stock's current price discounts slow progress, but meaningful re-rating requires tangible evidence of large new contracts and sustained cash flow generation beyond lumpy gains.

Implication

Over 6-18 months, if Anterix converts its pipeline into $250M+ contracted proceeds and demonstrates TowerX/CatalyX revenue, the stock could re-rate toward $26-$34; until then, the risk/reward is balanced and a wait approach is advised.

Thesis delta

The Q4 call marginally improves sentiment on utility momentum, but the thesis remains centered on execution risk and cash flow sustainability; no fundamental change to the waiting approach.